🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
If a treated cancer patient cannot make antibodies to a Severe Acute Respir...
Status
Terminated
Location
Compassionate Cancer Care Medical Group
Start Date
2022-06-03
Trial ID
NCT05438498
Treatments Being Tested
This study looks at the safety and effectiveness of AZD7442 in treating COV...
Status
Completed
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
Start Date
2021-02-10
Trial ID
NCT05780437
Treatments Being Tested
To evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynami...
Status
Completed
Location
Research Site
Start Date
2021-10-09
Trial ID
NCT05437289
Treatments Being Tested
To evaluate the safety and tolerability of a single dose of 600 mg AZD7442 ...
Status
Completed
Location
Research Site
Start Date
2021-12-03
Trial ID
NCT05184062
Treatments Being Tested
Drug studies often look at the effect one or two drugs have on a medical co...
Status
Completed
Location
Pinnacle Research Group (Site 1082), 321 E. 10th Street
Start Date
2020-08-19
Trial ID
NCT04518410
Treatments Being Tested
A Phase II Randomized, Open-label, Multicenter, Dose-ranging Study in Adult...
Status
Terminated
Location
Research Site
Start Date
2022-06-09
Trial ID
NCT05375760
AZD3152, a single mAb, is being developed to have broad neutralizing activi...
Status
Completed
Location
Research Site
Start Date
2022-12-16
Trial ID
NCT05648110
Treatments Being Tested
DisCoVeRy is a randomized controlled trial among adults (≥18-year-old) hosp...
Status
Completed
Location
Medizinische Universität Innsbruck
Start Date
2020-03-22
Trial ID
NCT04315948
AZD7442 mAbs are being evaluated for administration to prevent or treat COV...
Status
Completed
Location
Research Site
Start Date
2021-03-16
Trial ID
NCT04896541